ArticleCell cycle (Georgetown, Tex.)

NEDD4 is a biomarker of a poor prognosis that contributes to the progression and chemoresistance in small cell lung cancer.

Rong Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.